Copyright © 2006 American Chemical Society
November 13, 2006 Cover
Volume 84, Issue 46
COVER: Double-stranded RNA.
Volume 84, Issue 46
DRUG DELIVERY
Developing siRNA therapeutics depends on synthetic delivery systems
COVER: Double-stranded RNA.
Credit: Illustration by KennethEward/BioGrafic
» Full Article
November 13, 2006 Issue
Volume 84, Issue 46
November 13, 2006 Issue, Vol. 84 | Iss. 46
Developing siRNA therapeutics depends on synthetic delivery systems
(pp. 16-23)
Features
Government & Policy
Many companies tolerate risky practices that may lead to deadly accidents, chemical safety board says (pp. 31-33)
Science & Technology
French chemist carries out phosphorus research with one foot in the U.S. and the other in China (pp. 36-37)
News of the Week
Abbott to Buy Kos
$3.7 billion acquisition is targeted at the lipid management market
(p.11)Purifying Nanotubes
Plasma process selectively destroys metallic tubes
(p.11)Cleaning Water With 'Nanorust'
Magnetite nanoparticles effectively remove arsenic from water
(p.12)Bayer Consolidates
Firm will close two major research labs in the U.S., eliminating 600 R&D positions
(p.13)Reactions Need Just A Pinch of Organocatalyst
Highly enantioselective transformations proceed with unusually small amounts of catalyst
(p.13)'Frustrated' Solid Sucks Up Gases
Discovery opens new realm of sorptive materials
(p.14)Ancient Teeth
Gentler laser mass spec method opens door to study of small and fragile fossils
(p.14)Departments
Business
Chief Technology Officer Banholzer directs the firm's scientists to pursue raw material and process advances
(p.28)
A chemist from modest origins creates a formidable analytical testing business
(p.29)Concentrates
(pp. 25-26)
(pp. 25-26)- BASF will cut jobs
- GE Plastics opens Japan tech center
- Changes Afoot in Rubber Businesses
- Novartis TO START R&D in Shanghai
- Lonza, Genentech in biopharma deal
- H.B. Fuller Names New CEO
- OSI leaves eye disease business
- Plant revamp at Albany Molecular
- Kemira buys Chinese water treatment firm
- Wyeth inks protein deal with Ablynx ...
- ... And DNA vaccine pact with Inovio
- DSM invests in genetic test firm
- October jobs recover
- 3M will exit branded drugs
- BUSINESS ROUNDUP
ACS News
Government & Policy
Many companies tolerate risky practices that may lead to deadly accidents, chemical safety board says
(pp. 31-33)
There is desperate need for strong leadership and fresh thinking to keep nuclear weapons under control
(p.34)
Science & Technology
Developing siRNA therapeutics depends on synthetic delivery systems
(pp. 16-23)
Technology and Business news for the laboratory world
(p.39)
French chemist carries out phosphorus research with one foot in the U.S. and the other in China
(pp. 36-37)